Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALTO-100 in Adults With Bipolar Depression
NCT06656416Phase 2Recruiting
- Sponsor
- Alto Neuroscience
- Start
- Oct 2024
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of amdiglurax in bipolar disorder (BD), sponsored by Alto Neuroscience. Started Oct 2024; status: recruiting.
02
Drugs
amdiglurax
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT06656416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06656416.